First PREMIER Bank’s AstraZeneca AZN Stock Holding History

First PREMIER Bank’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-15	Closed	-$2K	–	409
2024 Q2	$2K	Hold	15	–	–	﹤0.01%	378
2024 Q1	$2K	Buy	+15	New	+$1.99K	﹤0.01%	433
2019 Q1	–	Sell	-590	Closed	-$44K	–	287
2018 Q4	$44K	Hold	590	–	–	0.03%	143
2018 Q3	$47K	Hold	590	–	–	0.03%	143
2018 Q2	$41K	Hold	590	–	–	0.03%	142
2018 Q1	$41K	Hold	590	–	–	0.03%	143
2017 Q4	$41K	Hold	590	–	–	0.03%	147
2017 Q3	$40K	Hold	590	–	–	0.03%	142
2017 Q2	$40K	Hold	590	–	–	0.03%	130
2017 Q1	$37K	Buy	590 +72	+14%	+$4.19K	0.03%	132
2016 Q4	$28K	Hold	518	–	–	0.02%	141
2016 Q3	$34K	Buy	+518	New	+$33.9K	0.03%	147

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

First PREMIER Bank's AZN Position: Q3 2024 in Review

First PREMIER Bank sold out of AstraZeneca (AZN) in Q3 2024, closing a stake of 15 shares — an estimated $2K sold.

First PREMIER Bank first reported a position in AZN in Q3 2016 and held it in 12 quarters. The position peaked at $47K in Q3 2018. 1,230 funds tracked by Wall St. Rank hold AZN as of Q3 2024.

First PREMIER Bank reported no remaining AstraZeneca position as of Q3 2024 after selling out during the quarter.
First PREMIER Bank sold 15 AstraZeneca shares in Q3 2024, an estimated $2K.
First PREMIER Bank first reported a position in AstraZeneca in Q3 2016 and held it in 12 quarters.
First PREMIER Bank's AstraZeneca position peaked at $47K in Q3 2018.
1,230 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2024.

Based on First PREMIER Bank's 13F filing for Q3 2024, filed 8 Oct 2024.